Finnrick - Ensuring a Safer and More Transparent Supply Chain
Xiangruida XDR

Xiangruida XDR
Retatrutide

Finnrick tested 2 samples of Retatrutide (GLP-1, GIP, and GCGR antagonist) from Xiangruida XDR between 20 Jun 2025 and 24 Jul 2025. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).

Finnrick Rating™
A
GREAT
Tentative Rating
Xiangruida XDR
Retatrutide
Tested 2 Samples
Last test 24 Jul 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Retatrutide tests from top-rated vendors:

All Retatrutide tests from Xiangruida XDR

Samples are tested in commercial labs

Tests Count

2

Scores

AVG8.2MIN7.6MAX8.8

Last

24 Jul 2025

First

20 Jun 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
24 Jul 2025View7.615mg16.470mg+9.8%99.51%2025/06/02White Label / Silver Crimp / Orange Cap Lab APublic
20 Jun 2025View8.815mg15.500mg+3.3%99.38%2025.02.22White Label / Silver Crimp / Clear Red CapLab EPublic